Defective ribosomal products challenge nuclear function by impairing nuclear condensate dynamics and immobilizing ubiquitin.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 10 12 2018
revised: 05 06 2019
accepted: 07 06 2019
pubmed: 5 7 2019
medline: 24 12 2019
entrez: 5 7 2019
Statut: ppublish

Résumé

Nuclear protein aggregation has been linked to genome instability and disease. The main source of aggregation-prone proteins in cells is defective ribosomal products (DRiPs), which are generated by translating ribosomes in the cytoplasm. Here, we report that DRiPs rapidly diffuse into the nucleus and accumulate in nucleoli and PML bodies, two membraneless organelles formed by liquid-liquid phase separation. We show that nucleoli and PML bodies act as dynamic overflow compartments that recruit protein quality control factors and store DRiPs for later clearance. Whereas nucleoli serve as constitutive overflow compartments, PML bodies are stress-inducible overflow compartments for DRiPs. If DRiPs are not properly cleared by chaperones and proteasomes due to proteostasis impairment, nucleoli undergo amyloidogenesis and PML bodies solidify. Solid PML bodies immobilize 20S proteasomes and limit the recycling of free ubiquitin. Ubiquitin depletion, in turn, compromises the formation of DNA repair compartments at fragile chromosomal sites, ultimately threatening cell survival.

Identifiants

pubmed: 31271238
doi: 10.15252/embj.2018101341
pmc: PMC6669919
doi:

Substances chimiques

Molecular Chaperones 0
Ubiquitin 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e101341

Subventions

Organisme : Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)
Pays : International
Organisme : Fondazione Cariplo (Cariplo Foundation)
ID : 2014-0703
Pays : International
Organisme : Ministero degli Affari Esteri e della Cooperazione Internazionale (MAECI)
Pays : International
Organisme : EU Joint Programme - Neurodegenerative Disease Research (JPND)
ID : 643417
Pays : International
Organisme : EMBO Long-Term fellowship
ID : ALTF 406-2017
Pays : International
Organisme : EC|H2020|H2020 Priority Excellent Science|H2020 European Research Council (ERC)
ID : 725836
Pays : International
Organisme : Bundesministerium für Bildung und Forschung (BMBF)
ID : 01ED1601A
Pays : International
Organisme : Bundesministerium für Bildung und Forschung (BMBF)
ID : 031A359A
Pays : International

Informations de copyright

© 2019 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006-16
pubmed: 17928811
Biochem J. 2012 May 1;443(3):851-6
pubmed: 22417684
Cell Rep. 2014 Sep 11;8(5):1365-79
pubmed: 25159147
Nucleic Acids Res. 2010 Nov;38(21):7388-99
pubmed: 20663773
Nature. 2000 Apr 13;404(6779):770-4
pubmed: 10783891
Biochemistry. 1997 Nov 25;36(47):14418-29
pubmed: 9398160
Mol Biol Cell. 2013 Sep;24(18):2943-53
pubmed: 23904269
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12038-43
pubmed: 11572931
Mol Cell. 2006 Nov 3;24(3):331-9
pubmed: 17081985
Cold Spring Harb Protoc. 2016 Aug 01;2016(8):
pubmed: 27480717
Biochim Biophys Acta. 2014 Jan;1843(1):216-21
pubmed: 23684952
J Neurosci. 2010 Jun 2;30(22):7729-39
pubmed: 20519548
Nature. 2015 Sep 3;525(7567):129-33
pubmed: 26308899
Elife. 2013 Jan 22;2:e00308
pubmed: 23358411
J Cell Biol. 2011 Apr 4;193(1):97-108
pubmed: 21444690
Cell Rep. 2013 Nov 14;5(3):781-90
pubmed: 24183671
Curr Biol. 2002 Jan 8;12(1):1-11
pubmed: 11790298
EMBO J. 2017 Oct 16;36(20):2931-2950
pubmed: 28916614
Nat Cell Biol. 2011 Mar;13(3):243-53
pubmed: 21317883
Mol Cell. 2014 Jul 3;55(1):15-30
pubmed: 24882209
Curr Opin Genet Dev. 2017 Jun;44:125-134
pubmed: 28365506
Cell Cycle. 2009 Jan 15;8(2):185-90
pubmed: 19158489
Histochem Cell Biol. 2007 Jun;127(6):591-601
pubmed: 17205305
Mol Cell. 2004 Dec 22;16(6):1027-34
pubmed: 15610744
Cell Rep. 2018 Aug 14;24(7):1713-1721.e4
pubmed: 30110628
Cell Mol Life Sci. 2000 Mar;57(3):450-63
pubmed: 10823246
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13546-51
pubmed: 23898190
Mol Cell. 2012 Jan 27;45(2):147-57
pubmed: 22284675
Nat Cell Biol. 2011 Oct 23;13(11):1376-82
pubmed: 22020440
Oncogene. 2017 Apr 27;36(17):2405-2422
pubmed: 27841863
Science. 2002 Mar 8;295(5561):1852-8
pubmed: 11884745
Nature. 2015 Nov 19;527(7578):389-93
pubmed: 26503038
J Cell Sci. 2005 Nov 15;118(Pt 22):5231-42
pubmed: 16249232
Science. 2014 Sep 5;345(6201):1139-45
pubmed: 25081482
EMBO J. 2019 Aug 1;38(15):e101341
pubmed: 31271238
PLoS One. 2014 Jun 09;9(6):e99346
pubmed: 24911415
J Biol Chem. 2006 Jan 6;281(1):392-400
pubmed: 16263705
Mol Cell. 2016 Sep 1;63(5):796-810
pubmed: 27570075
Curr Opin Cell Biol. 2017 Feb;44:44-50
pubmed: 28236735
Cell. 2016 Jul 28;166(3):651-663
pubmed: 27374333
PLoS One. 2017 Jan 4;12(1):e0169054
pubmed: 28052107
Mol Cell. 2005 Apr 1;18(1):1-12
pubmed: 15808504
Cancer Res. 2007 Aug 1;67(15):7395-405
pubmed: 17671210
Annu Rev Biochem. 2001;70:603-47
pubmed: 11395418
Oncogene. 2011 Feb 17;30(7):790-805
pubmed: 20956947
Cell. 2012 Sep 14;150(6):1182-95
pubmed: 22980979
Lancet Neurol. 2018 Jan;17(1):94-102
pubmed: 29154141
Curr Biol. 2014 May 19;24(10):R463-74
pubmed: 24845679
J Cell Biol. 2018 Jan 2;217(1):51-63
pubmed: 29127110
Trends Pharmacol Sci. 2015 Feb;36(2):72-7
pubmed: 25636813
Dev Cell. 2016 Oct 24;39(2):155-168
pubmed: 27720612
EMBO J. 2017 Jun 14;36(12):1669-1687
pubmed: 28377462
Cell. 2007 Nov 30;131(5):887-900
pubmed: 18001824
J Biol Chem. 2003 Feb 14;278(7):4699-704
pubmed: 12468532
Cell. 2009 Feb 6;136(3):435-46
pubmed: 19203579
Cell. 2016 Oct 20;167(3):774-788.e17
pubmed: 27768896
Curr Opin Cell Biol. 2018 Jun;52:154-161
pubmed: 29723661
Nat Methods. 2008 May;5(5):409-15
pubmed: 18391959
Cell. 2000 May 12;101(4):341-4
pubmed: 10830160
Nat Rev Mol Cell Biol. 2016 May 23;17(6):379-94
pubmed: 27211488
J Mol Biol. 2018 Nov 2;430(23):4711-4729
pubmed: 29758260
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Nat Neurosci. 2017 Sep;20(9):1225-1235
pubmed: 28714954
PLoS Genet. 2013;9(8):e1003680
pubmed: 23935537
Trends Genet. 2018 Mar;34(3):218-231
pubmed: 29352613
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7607-12
pubmed: 19383787

Auteurs

Laura Mediani (L)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Jordina Guillén-Boixet (J)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Jonathan Vinet (J)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Genomic and post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy.

Titus M Franzmann (TM)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Ilaria Bigi (I)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Daniel Mateju (D)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Arianna D Carrà (AD)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Federica F Morelli (FF)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Tatiana Tiago (T)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Ina Poser (I)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Simon Alberti (S)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Technische Universität Dresden, Center for Molecular and Cellular Bioengineering (CMCB), Biotechnology Center (BIOTEC), Dresden, Germany.

Serena Carra (S)

Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH